| Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
|---|
| 05/14/2008 | EP1919451A2 Application of a bioactive agent in a solvent composition to produce a target particle morphology |
| 05/14/2008 | EP1575922B1 Biphenyl derivatives and their use as fungicides |
| 05/14/2008 | CN101180295A Tetrahydropyrane derivatives comprising several rings containing oxygen and method for the production thereof |
| 05/14/2008 | CN101180287A Method for producing 2,5-substituted tetrahydropyran derivatives by reductive elimination of the corresponding 4-halogen derivative |
| 05/14/2008 | CN101180286A Method for producing tetrahydropyran derivatives |
| 05/14/2008 | CN101180285A Formyltetrahydropyrans, method for the production thereof and use thereof in the production of liquid crystal compounds |
| 05/14/2008 | CN101180284A Method for producing tetrahydropyranes from tetrahydropyran-3-ones |
| 05/13/2008 | US7371766 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 05/08/2008 | WO2008053360A2 Albumin binding molecules and uses thereof |
| 05/08/2008 | WO2008053206A2 Process for preparation of aldonic acids and derivatives thereof |
| 05/08/2008 | WO2008052930A2 Preparation of 4-alk0xy-7- (tetrahydropyran-4-yl) benzothiazol-2-amine derivatives |
| 05/08/2008 | WO2008024302A8 Compounds for treating proliferative disorders |
| 05/08/2008 | US20080108838 Novel chiral heptyne derivatives for the preparation of epothilones and processes for their preparation |
| 05/08/2008 | CA2669726A1 Albumin binding molecules and uses thereof |
| 05/07/2008 | EP1735295B1 Antiinflammatory lactones |
| 05/07/2008 | EP1720849B1 Pyranone derivatives useful for treating cancer |
| 05/07/2008 | EP1592680B1 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/07/2008 | EP1344109B1 Onium salts and the use therof as latent acids |
| 05/07/2008 | CN101175777A (methyl)acrylamide derivative, polymer, chemically amplified photosensitive resin composition, and method for forming pattern |
| 05/07/2008 | CN101172957A Selective inhibitors of viral or bacterial neuraminidase |
| 05/07/2008 | CN101172930A 2.4-dihalogen-6-(C2-C3-alkyl)-phenyl substituted tetramic acid derivatives |
| 05/07/2008 | CN100386313C Novel herbicides |
| 05/06/2008 | US7368585 Protected trihydroxyisoalkatrienyltriphenylphosphonium halides for proparing polyhydroxylactones; acid stable protecting groups include p-methoxybenzyl and tert-butyldimethylsilyl. |
| 04/30/2008 | EP1915387A1 Novel glucopyranose esters and glucofuranose esters of alkyl- fumarates and their pharmaceutical use |
| 04/30/2008 | CN101168539A Method for extracting salvianolic acid B and hydroxysafflor Yellow A and preparation method of Danhong for injection |
| 04/29/2008 | US7365215 Process for preparing 4-aminotetrahydropyran compound and an acid salt thereof, synthetic intermediate thereof and process for preparing the same |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7364804 Pyran derivative, method for manufacturing the same, and light-emitting element containing the pyran derivative |
| 04/29/2008 | CA2355230C Cyclohexenone oxime ether / (glyphosates / gluphosinates) suspension concentrates |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/24/2008 | US20080096869 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/23/2008 | EP1912964A2 Dihydroxyanthraquinones and their use |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN100383665C Onium salts and the use therof as latent acids |
| 04/23/2008 | CN100383254C Adducts based on cyclic compounds and the use thereof as tanning agents and curing agents |
| 04/22/2008 | US7361765 resides in the superior properties of the succinate salt of ((1R,3S)-3-isopropyl-3-{[3-(trifluoromethyl)-7,8-dihydro-1,6-naphthyridin-6(5H)-yl]carbonyl}cyclopentyl)[(3S,4S)-3-methoxytetrahydro-2H-pyran-4-yl]amine |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361388 Liquid-crystalline compounds having a tetrahydropyran ring |
| 04/17/2008 | WO2008044339A1 Therapeutic/preventive agent for intraocular disease containing statin compound |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/16/2008 | CN101161653A Method for preparing novel Pranoprofen key intermediates |
| 04/16/2008 | CN101161649A Method for synthesizing lactone compound by catalytic oxidation of cyclone |
| 04/16/2008 | CN100381432C Pyronone antibiotic, its preparation method and application |
| 04/10/2008 | WO2008042688A2 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/10/2008 | US20080085910 For inflammatory bowel disease; oral administration, bioavailability, pharmacokinetics; 2-(2,6-Dichlorobenzamido)-5-[4-(ethyl-pyrimidin-2-ylamino)phenyl]pent-4-enoic acid methyl ester for example |
| 04/10/2008 | US20080083902 an 1-alkoxy-2,3-difluoro-4-cyclohexylenyl-benzene, and a 4,4'(alkyl, alkenyl or alkoxy) bicyclohexyl or a (4 or 4')-(alkyl, alkenyl or alkoxy)phenyl cyclohexane; high specific resistance, short response times, low threshold voltage; for electro-optical liquid-crystal dispaly |
| 04/10/2008 | CA2664688A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/09/2008 | EP1908757A1 Choline salt crystal of azulene compound |
| 04/09/2008 | EP1907371A1 Process for preparing 2-methoxycarbonylmethyl-6,6-dimethyl-2- tetrahydropyran carboxylic acid |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP1309565B1 Heterocyclic mutilin esters and their use as antibacterials |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN101160286A Process for the preparation of ccr-2 antagonist |
| 04/09/2008 | CN101157677A Method for catalytic preparation of delta-valerolactone by using supported nano-gold catalyst |
| 04/08/2008 | US7354936 2-phenylpyran-4-one derivatives |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008037603A1 Process for extracting phloridzine from apple seeds |
| 04/03/2008 | WO2007135565A3 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | US20080081807 Arylphenyl-substituted cyclic keto-enols |
| 04/03/2008 | DE102007040400A1 Indanverbindungen Indane compounds |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/02/2008 | EP1905766A1 Glycolipid derivative and therapeutic agent comprising the same as active ingredient |
| 04/02/2008 | EP1904485A2 Synthesis and complete stereochemical assignment of psymberin/irciniastatin for anti-tumor use |
| 04/02/2008 | CN101155794A Crystalline form of 1-chloro-4-(ss-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 04/02/2008 | CN101155789A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 04/02/2008 | CN101153029A Method for purifying fluorocarbon solvent |
| 04/02/2008 | CN100378091C Process for the preparation of 2-(6-substituted-1,-3-dioxane-4-yl) acetic acid derivatives |
| 04/01/2008 | US7351851 Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 04/01/2008 | US7351822 Serine protease inhibitors |
| 04/01/2008 | US7351738 e.g., phenyl ((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)carbamate; inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide |
| 04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 03/27/2008 | WO2008036247A1 Renin inhibitors |
| 03/27/2008 | WO2008036216A1 Piperidine derivatives as renin inhibitors |
| 03/27/2008 | WO2008034859A1 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 03/27/2008 | WO2008034511A1 Indane compounds for use as components of liquid crystal media |
| 03/27/2008 | WO2007038829A8 Method of drug design |
| 03/27/2008 | US20080076800 Anticancer, inflammation, arthritis, angiogenesis, neurodegenerative diseases, fungal infections, malaria; Heat-shock protein 90 inhibitors; 4-(6,6-Dimethyl-4-oxo-3-methyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(3,4,5-trimethoxyanilino)-benzamide |
| 03/27/2008 | US20080075891 Chlorofluorobenzene liquid crystal compound, liquid crystal composition and liquid crystal display device |
| 03/27/2008 | DE102007038618A1 Fluorphenyl-Verbindungen für flüssigkristalline Mischungen Fluorophenyl compounds for liquid crystalline mixtures |
| 03/27/2008 | CA2664095A1 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 03/27/2008 | CA2663263A1 Renin inhibitors |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/25/2008 | US7348450 Etherification of 4-Methoxy-6-trifluoromethylpyran-2-one with dimethyl sulfate, converting to the alkyl ester with an alkali or alkaline earth metal alcoholate; chemical intermediate for insecticides |
| 03/25/2008 | US7348436 Compounds useful for the synthesis of (+)-discodermolide and methods thereof |
| 03/25/2008 | CA2484638C Polyene polyketides and methods of production |
| 03/20/2008 | WO2008032156A1 Diaryl ether derivatives and uses thereof |
| 03/20/2008 | US20080071098 Hydrogenation of esters with ru/tetradentate ligands complexes |
| 03/20/2008 | US20080070918 Heat Shock Protein-90 (HSP-90) inhibitors; cancer, inflammation, arthritis, angiogenesis, antimalaria, fungal and viral infections; 2-(4-Hydroxy-cyclohexylamino)-4-(3,7,7-trimethyl-5-oxo-5,6,7,8-tetrahydro-4H-cinnolin-1-yl)-benzamide for example; synthesis from corresponding benzonitriles |
| 03/20/2008 | US20080070916 Treating disorders such as proliferative diseases, and cancer; compounds can act as probes of biological function; libraries; for example, 2-ethoxy-3-(2-hydroxyethoxyethoxyethyl)-4-(1-acetylindol-3-yl)-6-(morpholinocarbonyl)-2H-3,4-dihydropyran |
| 03/20/2008 | US20080070887 Diaryl Ether Derivatives and Uses Thereof |
| 03/19/2008 | EP1899294A1 Therapeutic agents |
| 03/19/2008 | CN101146779A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 03/19/2008 | CN101144169A Method for producing DL-homocysteine lactone hydrochlorate |
| 03/19/2008 | CN101143860A 5,6-dihydropyrane and preparation method for derivative thereof |
| 03/19/2008 | CN101143859A Novel compound, its synthesis method and therapeutical uses |
| 03/13/2008 | WO2007136116A3 C-phenyl glycitol compound for the treatment of diabetes |